Literature DB >> 21660507

A scaffold for X chromosome inactivation.

Anna Tattermusch1, Neil Brockdorff.   

Abstract

X chromosome inactivation (XCI), the silencing of one of the two X chromosomes in XX female cells, equalises the dosage of X-linked genes relative to XY males. The process is mediated by the non-coding RNA X inactive specific transcript (Xist) that binds in cis and propagates along the inactive X chromosome elect, triggering chromosome-wide silencing. The mechanisms by which Xist RNA binds and spreads along the chromosome, and initiates Xist-mediated chromosome silencing remain poorly understood. Accumulating evidence suggests that chromosome and nuclear organisation are important in both processes. Notably, recent studies have identified specific factors, previously shown to be components of the nuclear matrix or scaffold, to play a role both in Xist RNA-binding and in Xist-mediated silencing. In this review we provide a perspective on these studies in the context of previous work on chromosome/nuclear architecture in XCI.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21660507     DOI: 10.1007/s00439-011-1027-4

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  59 in total

1.  Chromosomal silencing and localization are mediated by different domains of Xist RNA.

Authors:  Anton Wutz; Theodore P Rasmussen; Rudolf Jaenisch
Journal:  Nat Genet       Date:  2002-01-07       Impact factor: 38.330

2.  PNA interference mapping demonstrates functional domains in the noncoding RNA Xist.

Authors:  A Beletskii; Y K Hong; J Pehrson; M Egholm; W M Strauss
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

Review 3.  Chromosome territories--a functional nuclear landscape.

Authors:  Thomas Cremer; Marion Cremer; Steffen Dietzel; Stefan Müller; Irina Solovei; Stanislav Fakan
Journal:  Curr Opin Cell Biol       Date:  2006-05-09       Impact factor: 8.382

Review 4.  The ribonucleoprotein structures along the pathway of mRNA formation.

Authors:  G Dreyfuss; Y D Choi; S A Adam
Journal:  Endocr Res       Date:  1989       Impact factor: 1.720

5.  Characterization of heterogeneous nuclear RNA-protein complexes in vivo with monoclonal antibodies.

Authors:  G Dreyfuss; Y D Choi; S A Adam
Journal:  Mol Cell Biol       Date:  1984-06       Impact factor: 4.272

6.  Specific interaction of mouse major satellite with MAR-binding protein SAF-A.

Authors:  I B Lobov; K Tsutsui; A R Mitchell; O I Podgornaya
Journal:  Eur J Cell Biol       Date:  2000-11       Impact factor: 4.492

7.  Long-range chromatin regulatory interactions in vivo.

Authors:  David Carter; Lyubomira Chakalova; Cameron S Osborne; Yan-feng Dai; Peter Fraser
Journal:  Nat Genet       Date:  2002-11-11       Impact factor: 38.330

8.  Attenuated spread of X-inactivation in an X;autosome translocation.

Authors:  Bilyana C Popova; Takashi Tada; Nobuo Takagi; Neil Brockdorff; Tatyana B Nesterova
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-05       Impact factor: 11.205

9.  Tissue-specific nuclear architecture and gene expression regulated by SATB1.

Authors:  Shutao Cai; Hye-Jung Han; Terumi Kohwi-Shigematsu
Journal:  Nat Genet       Date:  2003-05       Impact factor: 38.330

10.  Scaffold attachment factor A (SAF-A) is concentrated in inactive X chromosome territories through its RGG domain.

Authors:  Roger Helbig; Frank O Fackelmayer
Journal:  Chromosoma       Date:  2003-11-08       Impact factor: 4.316

View more
  22 in total

1.  A new 'Linc' between noncoding RNAs and blood development.

Authors:  Vikram R Paralkar; Mitchell J Weiss
Journal:  Genes Dev       Date:  2011-12-15       Impact factor: 11.361

2.  Leucine-rich repeat and WD repeat-containing protein 1 is recruited to pericentric heterochromatin by trimethylated lysine 9 of histone H3 and maintains heterochromatin silencing.

Authors:  Kui Ming Chan; Zhiguo Zhang
Journal:  J Biol Chem       Date:  2012-03-15       Impact factor: 5.157

3.  Inhibition of prostate cancer DU145 cell growth with small interfering RNA targeting the SATB1 gene.

Authors:  Qiang Wang; Chun-Sheng Yang; Zu-Xin Ma; Jia-Cun Chen; Jun-Nian Zheng; Xiao-Qing Sun; Jun-Qi Wang
Journal:  Exp Ther Med       Date:  2018-01-24       Impact factor: 2.447

4.  Mary Lyon and the hypothesis of random X chromosome inactivation.

Authors:  Peter S Harper
Journal:  Hum Genet       Date:  2011-08       Impact factor: 4.132

5.  The Xist lncRNA exploits three-dimensional genome architecture to spread across the X chromosome.

Authors:  Jesse M Engreitz; Amy Pandya-Jones; Patrick McDonel; Alexander Shishkin; Klara Sirokman; Christine Surka; Sabah Kadri; Jeffrey Xing; Alon Goren; Eric S Lander; Kathrin Plath; Mitchell Guttman
Journal:  Science       Date:  2013-07-04       Impact factor: 47.728

6.  miR-23a suppresses proliferation of osteosarcoma cells by targeting SATB1.

Authors:  Guangbin Wang; Bin Li; Yonghui Fu; Ming He; Jiashi Wang; Peng Shen; Lunhao Bai
Journal:  Tumour Biol       Date:  2015-01-27

Review 7.  Charity begins at home: non-coding RNA functions in DNA repair.

Authors:  Dipanjan Chowdhury; Young Eun Choi; Marie Eve Brault
Journal:  Nat Rev Mol Cell Biol       Date:  2013-02-06       Impact factor: 94.444

Review 8.  Guided by RNAs: X-inactivation as a model for lncRNA function.

Authors:  John E Froberg; Lin Yang; Jeannie T Lee
Journal:  J Mol Biol       Date:  2013-06-28       Impact factor: 5.469

9.  Site-specific silencing of regulatory elements as a mechanism of X inactivation.

Authors:  J Mauro Calabrese; Wei Sun; Lingyun Song; Joshua W Mugford; Lucy Williams; Della Yee; Joshua Starmer; Piotr Mieczkowski; Gregory E Crawford; Terry Magnuson
Journal:  Cell       Date:  2012-11-21       Impact factor: 41.582

10.  Silencing SATB1 inhibits proliferation of human osteosarcoma U2OS cells.

Authors:  Haiying Zhang; Shanshan Qu; Shuang Li; Yang Wang; Yulin Li; Yimin Wang; Zonggui Wang; Ronggui Li
Journal:  Mol Cell Biochem       Date:  2013-03-21       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.